In view of our recent demonstration that insulin inhibits the expression of
intercellular adhesion molecule-1 (ICAM-1) and the fact that ICAM-1 expres
sion is known to be modulated by nuclear factor-kappaB (NF kappaB), We have
now investigated whether insulin inhibits intranuclear NF kappaB binding a
ctivity. We have also investigated whether insulin inhibits the pro-inflamm
atory chemokine, monocyte chemoattractant protein-1 (MCP-1), which attracts
leucocytes to the inflamed sites and is also regulated by NF kappaB. insul
in was incubated with cultured human aortic endothelial cells (HAEC) at 0,
100 and 1000 muU/mL. Intranuclear NF kappaB binding activity was suppressed
by approximately 45 % at 100 muU/mL and by 60 % at 1000 muU/mL (p<0.05). M
CP-1 mRNA expression was also suppressed by 47% at 100 <mu>U/mL and by 79 %
at 1000 muU/mL (p<0.05). We conclude that insulin at physiologically relev
ant concentrations exerts an inhibitory effect on the cardinal pro-inflamma
tory transcription factor NF<kappa>B and the pro-inflammatory chemokine MCP
-1; these effects suggest an anti-inflammatory and potential anti-atherogen
ic affects of insulin.